Narrow Results Clear All
- Book/Report 12
- Legislation/Regulation 6
- Newspaper/Magazine Article 5
- Newsletter/Journal 1
- Special or Theme Issue 1
- Toolkit 3
- Web Resource
- Grant 1
- Meeting/Conference 5
- Press Release/Announcement 18
- Communication Improvement 13
- Culture of Safety 9
- Education and Training 14
Error Reporting and Analysis
- Error Reporting 6
Human Factors Engineering
- Checklists 10
- Legal and Policy Approaches 9
- Logistical Approaches 2
- Quality Improvement Strategies 19
- Specialization of Care 2
- Teamwork 3
- Technologic Approaches 13
- Device-related Complications 15
- Diagnostic Errors 2
- Discontinuities, Gaps, and Hand-Off Problems 1
- Identification Errors 3
- Interruptions and distractions 1
- Medical Complications 10
- Medication Errors/Preventable Adverse Drug Events 17
- Nonsurgical Procedural Complications 2
- Psychological and Social Complications 3
- Surgical Complications 3
- Internal Medicine 12
- Pharmacy 15
- Health Care Executives and Administrators 41
Health Care Providers
- Nurses 4
- Non-Health Care Professionals 22
- Patients 11
- Australia and New Zealand 1
- Europe 5
United States of America
United States Federal Government
- Department of Health and Human Services (HHS) 46
- United States Federal Government 51
- United States of America 54
Search results for "Human Factors Engineering"
- Government Resource
- Human Factors Engineering
NHS Improvement. July 2, 2019.
The United Kingdom National Health Service (NHS) has been at the forefront of patient safety innovation. This strategy seeks to further implement approaches that explore and optimize the intersection of systems and human behaviors to support safe care at the NHS. The framework builds upon the perspectives of patients, staff, and organizations to achieve whole system improvement and sustain those changes through effective intervention and program design.
Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.
Silver Spring, MD: US Food and Drug Administration; September 29, 2018.
Bethesda, MD: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. May 21, 2018. PA-18-790; PA-18-791.
FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 11, 2018.
Heparin-containing medical devices and combination products: recommendations for labeling and safety testing. Draft guidance for industry and Food and Drug Administration staff.
Federal Register. Washington, DC: US Department of Health and Human Services. Baltimore, MD: Food and Drug Administration. July 9, 2015;80:39440-39441.
FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam).
FDA Safety Communication. Silver Spring, MD: US Food and Drug Administration; May 20, 2015.
PA-PSRS Patient Saf Advis. June 2009;6:39-45.
This piece identifies risk factors associated with retention of foreign objects and suggests several tactics to prevent its occurrence.
Rockville, MD: Agency for Healthcare Research and Quality; September 2007. AHRQ Publication No. 07-0076-1.
This video uses the experiences of three US hospitals to demonstrate how the quality and safety of each hospital's patient care services were improved by implementing evidence-based hospital design into recent construction and renovation projects.
Healthcare Quality Directorate, Department of Health. London, England: Crown Publishing; February 16, 2007.
This report discusses the impact that automated technologies, such as radio frequency identification (RFID) and barcoding, could have on health care in the United Kingdom and provides a plan to support their adoption in the National Health Service.
Meeting/Conference > Government Resource
Public Meeting on Improving Patient Safety by Enhancing the Container Labeling for Parenteral Infusion Drug Products.
US Food and Drug Administration, Center for Drug Evaluation and Research. January 11, 2007.
The US Food and Drug Administration invited experts to comment on how labels for intravenous drugs could be designed to ensure the safe use of these medications through informed label redesign efforts.
Meeting/Conference > Government Resource
US Food and Drug Administration Center for Drug Evaluation and Research, Institute for Safe Medication Practices. November 7, 2006.
This teleconference discussed the 2006 FDA medication package insert design program and reviewed prescription drug labeling format changes. Handouts and an audio download of the presentation are available.
US Food and Drug Administration. March 8, 2019.
Errors of commission during complex procedures can contribute to patient harm. Drawing from an analysis of medical device reports submitted to the Food and Drug Administration, this announcement seeks to raise awareness of common adverse events associated with surgical staplers and implantable staples. User-related problems include opening of the staple line, misapplied staples, and staple gun difficulties. Recommendations include ensuring availability of various staple sizes and avoiding use of staples on large blood vessels.
Rizk S, Oguntebi G, Graber ML, Johnston D. Research Triangle Park, NC: RTI International; 2016.
Standard term selection tools—like pick lists or drop-down menus—in information technology can create opportunities for user error due to human factors. This publication explores how mistakes such as selecting the wrong drug from an ordering pick list can occur in the ambulatory environment. The report includes recommendations and resources to help enhance medication safety when using these tools.
Agency for Healthcare Research and Quality. Health Care Innovations Exchange. May 18, 2016.
Rockville, MD: Center for Drug Evaluation and Research, US Food and Drug Administration; April 2016.
Preventable tragedies: superbugs and how ineffective monitoring of medical device safety fails patients.
US Senate Health, Education, Labor, and Pensions Committee. January 13, 2016.
Insufficient sterilization of duodenoscopes and other medical equipment has been linked to health care–associated infection outbreaks. This report summarizes findings from a government investigation into existing methods for monitoring and reporting device problems and provides recommendations for Congress, hospitals, and the Food and Drug Administration to augment identification and prevention of safety issues associated with medical devices.
Leas BF, Sullivan N, Han JH, Pegues DA, Kaczmarek JL, Umscheid CA. Rockville, MD: Agency for Healthcare Research and Quality; August 2015. Technical Brief No. 22. AHRQ Publication No. 15-EHC020-EF.
FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; July 30, 2015.
Look-alike and sound-alike drug names can contribute to confusion and result in medication errors. To raise awareness of potential wrong-patient errors due to similarity between two proprietary names, this announcement describes near misses with the drugs at the prescribing and dispensing stage and suggests clinicians use the generic names for the medications to reduce risk of patient harm.
Zheng K, Ciemins EL, Lanham HJ, Lindberg C. Rockville, MD: Agency for Healthcare Research and Quality; July 2015. AHRQ Publication No. 15-0058-EF.
Ineffective implementation of health information technology (IT) can result in workarounds and other workflow changes that disrupt care delivery. This report examines how health IT implementation can affect clinician and staff workload in the ambulatory care environment, including increase interruptions and multitasking, and recommends workload considerations to enable staff to adapt to changes in practice.
Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning.
FDA Safety Communication. Silver Spring, MD: US Food and Drug Administration; February 23, 2015.
Design limitations and production pressure may contribute to insufficient sterilization of complicated medical devices between uses. This announcement raises awareness of risks associated with inadequate cleaning of duodenoscopes that surfaced after a cluster of nosocomial infections at Ronald Reagan UCLA Medical Center.